Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats-Reference-Cited by-同舟云学术

Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats

Published:2014-11 Issue:2 Volume:118 Page:297-305
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Čertíková Chábová Věra,Vernerová Zdenka,Kujal Petr,Husková Zuzana,Škaroupková Petra,Tesař Vladimír,Kramer Herbert J.,Kompanowska-Jezierska Elzbieta,Walkowska Agnieszka,Sadowski Janusz,Červenka Luděk,Vaněčková Ivana

Funder

Ministry of Health of the Czech Republic

Czech Science Foundation

Internal Grant Agency of the Ministry of Health

European Commission

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference47 articles.

1. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation;Barton;Biochem Biophys Res Commun,1997

2. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression;Benigni;Kidney Int,1993

3. ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells;Boesen;J Am Soc Nephrol,2011

4. Nephron adaptation to renal injury or ablation;Brenner;Am J Physiol,1985

5. Chronic kidney disease and vascular remodeling: molecular mechanisms and clinical implications;Briet;Clin Sci,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease;Clinical Science;2024-05-29

2. Endothelin Receptor Antagonists in Kidney Disease;International Journal of Molecular Sciences;2023-02-08

3. Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula;Biomedicine & Pharmacotherapy;2023-02

4. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension;Journal of Hypertension;2022-10-07

5. Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension;Biomedicine & Pharmacotherapy;2021-12